These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11964525)

  • 1. The human 26S proteasome is a target of antiretroviral agents.
    Piccinini M; Rinaudo MT; Chiapello N; Ricotti E; Baldovino S; Mostert M; Tovo PA
    AIDS; 2002 Mar; 16(5):693-700. PubMed ID: 11964525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HIV protease inhibitors nelfinavir and saquinavir, but not a variety of HIV reverse transcriptase inhibitors, adversely affect human proteasome function.
    Piccinini M; Rinaudo MT; Anselmino A; Buccinnà B; Ramondetti C; Dematteis A; Ricotti E; Palmisano L; Mostert M; Tovo PA
    Antivir Ther; 2005; 10(2):215-23. PubMed ID: 15865215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells.
    Pajonk F; Himmelsbach J; Riess K; Sommer A; McBride WH
    Cancer Res; 2002 Sep; 62(18):5230-5. PubMed ID: 12234989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ionizing radiation affects 26s proteasome function and associated molecular responses, even at low doses.
    Pajonk F; McBride WH
    Radiother Oncol; 2001 May; 59(2):203-12. PubMed ID: 11325450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of 26S proteasomes from human and mouse spermatozoa.
    Tipler CP; Hutchon SP; Hendil K; Tanaka K; Fishel S; Mayer RJ
    Mol Hum Reprod; 1997 Dec; 3(12):1053-60. PubMed ID: 9464850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasomes are a target of the anti-tumour drug vinblastine.
    Piccinini M; Tazartes O; Mezzatesta C; Ricotti E; Bedino S; Grosso F; Dianzani U; Tovo PA; Mostert M; Musso A; Rinaudo MT
    Biochem J; 2001 Jun; 356(Pt 3):835-41. PubMed ID: 11389692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and incidence of resistance to zidovudine and other antiretroviral drugs.
    Mayers DL
    Am J Med; 1997 May; 102(5B):70-5. PubMed ID: 9845501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.
    Palombella VJ; Rando OJ; Goldberg AL; Maniatis T
    Cell; 1994 Sep; 78(5):773-85. PubMed ID: 8087845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP binding cassette multidrug transporters limit the anti-HIV activity of zidovudine and indinavir in infected human macrophages.
    Jorajuria S; Dereuddre-Bosquet N; Becher F; Martin S; Porcheray F; Garrigues A; Mabondzo A; Benech H; Grassi J; Orlowski S; Dormont D; Clayette P
    Antivir Ther; 2004 Aug; 9(4):519-28. PubMed ID: 15456083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel in vitro assay for deubiquitination of I kappa B alpha.
    Strayhorn WD; Wadzinski BE
    Arch Biochem Biophys; 2002 Apr; 400(1):76-84. PubMed ID: 11913973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.
    Staszewski S; Keiser P; Montaner J; Raffi F; Gathe J; Brotas V; Hicks C; Hammer SM; Cooper D; Johnson M; Tortell S; Cutrell A; Thorborn D; Isaacs R; Hetherington S; Steel H; Spreen W;
    JAMA; 2001 Mar; 285(9):1155-63. PubMed ID: 11231744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymes catalyzing ubiquitination and proteolytic processing of the p105 precursor of nuclear factor kappaB1.
    Coux O; Goldberg AL
    J Biol Chem; 1998 Apr; 273(15):8820-8. PubMed ID: 9535861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53.
    Herrmann JL; Briones F; Brisbay S; Logothetis CJ; McDonnell TJ
    Oncogene; 1998 Dec; 17(22):2889-99. PubMed ID: 9879995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination shows reduction in viral levels.
    AIDS Patient Care STDS; 1996 Jun; 10(3):184. PubMed ID: 11361623
    [No Abstract]   [Full Text] [Related]  

  • 15. The triple combination indinavir-zidovudine-lamivudine is highly synergistic.
    Snyder S; D'Argenio DZ; Weislow O; Bilello JA; Drusano GL
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1051-8. PubMed ID: 10722511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysis.
    Gaedicke S; Firat-Geier E; Constantiniu O; Lucchiari-Hartz M; Freudenberg M; Galanos C; Niedermann G
    Cancer Res; 2002 Dec; 62(23):6901-8. PubMed ID: 12460905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV antiretroviral drug combination induces endothelial mitochondrial dysfunction and reactive oxygen species production, but not apoptosis.
    Jiang B; Hebert VY; Li Y; Mathis JM; Alexander JS; Dugas TR
    Toxicol Appl Pharmacol; 2007 Oct; 224(1):60-71. PubMed ID: 17669453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of direct degradation of IkappaBalpha by 20S proteasome.
    Alvarez-Castelao B; Castaño JG
    FEBS Lett; 2005 Aug; 579(21):4797-802. PubMed ID: 16098527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells.
    Giuliano M; Lauricella M; Calvaruso G; Carabillò M; Emanuele S; Vento R; Tesoriere G
    Cancer Res; 1999 Nov; 59(21):5586-95. PubMed ID: 10554039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
    Taylor DL; Ahmed PS; Tyms AS; Wood LJ; Kelly LA; Chambers P; Clarke J; Bedard J; Bowlin TL; Rando RF
    Antivir Chem Chemother; 2000 Jul; 11(4):291-301. PubMed ID: 10950391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.